Company intelligence / Profile preview

Balmoral Pharmacy

Northampton, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Balmoral Pharmacy Ltd. operates as a private, independent pharmacy providing healthcare services and dispensing medication. It is also listed as sponsor for clinical trials, e.g. Phase 3 trial for a transdermal device for amputations, and is associated with a pending drug (GDC-695) for actinic keratosis.

Therapeutic areas: DermatologyOther
Modalities: Small moleculeBiologic
Industry: Non-Academic Healthcare

Partnerships

Gage Development Company, LLC

Beyond the preview

Go deeper on Balmoral Pharmacy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Balmoral Pharmacy.

Explore the full profile